G J Grover Selected Research

BMS 180448

5/2004	[The effect of K(ATP)-channel activation on the electrical stability of myocardium in rats with postinfarction cardiosclerosis].
4/2003	[Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation].
6/2001	Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G J Grover Research Topics

Disease

2	Ventricular Fibrillation 05/2004 - 04/2003
2	Ischemia 06/2001 - 04/2000
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2001 - 05/2000
1	Dyslipidemias (Dyslipidemia) 01/2007
1	Metabolic Diseases (Metabolic Disease) 01/2007
1	Sclerosis 04/2003
1	Fibrosis (Cirrhosis) 04/2003
1	Contracture 06/2001
1	Ischemic Contracture 06/2001
1	Hypertension (High Blood Pressure) 01/2001
1	Thrombosis (Thrombus) 01/2001
1	Stroke (Strokes) 01/2001
1	Obesity 09/2000
1	Body Weight (Weight, Body) 09/2000
1	Neoplasms (Cancer) 05/2000

Drug/Important Bio-Agent (IBA)

3	Adenosine Triphosphate (ATP)IBA 05/2004 - 04/2000
3	BMS 180448IBA 05/2004 - 06/2001
1	LigandsIBA 01/2007
1	HMR 1098IBA 04/2003
1	CatecholaminesIBA 04/2003
1	Diazoxide (Hyperstat)FDA Link 04/2003
1	KATP ChannelsIBA 04/2003
1	BMS 191095IBA 06/2001
1	Cromakalim (Levcromakalim)IBA 06/2001
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2001
1	ifetrobanIBA 01/2001
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2000
1	Adenosine Triphosphatases (ATPase)IBA 09/2000
1	GC 1 compoundIBA 09/2000
1	LipidsIBA 09/2000
1	Oxygen (Dioxygen)IBA 05/2000

Therapy/Procedure

1	Intravenous Administration 05/2004